Nanogroup SA (NNG) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.141x

Based on the latest financial reports, Nanogroup SA (NNG) has a cash flow conversion efficiency ratio of -0.141x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-1.60 Million ≈ $-440.62K USD) by net assets (zł11.37 Million ≈ $3.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Nanogroup SA to measure how many days the company can operate on defensive assets alone.

Nanogroup SA - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Nanogroup SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nanogroup SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanogroup SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Step One Clothing Ltd
AU:STP
-0.118x
TMD Energy Limited
NYSE MKT:TMDE
N/A
YBS International Bhd
KLSE:0025
0.020x
Ashford Hospitality Trust Inc
NYSE:AHT
-0.140x
Sidma S.A. Steel Products
AT:SIDMA
0.036x
Welcron Company Limited
KQ:065950
0.184x
Medifron DBT Co. Ltd
KQ:065650
-0.472x
CS Corporation
KQ:065770
-0.030x

Annual Cash Flow Conversion Efficiency for Nanogroup SA (2015–2024)

The table below shows the annual cash flow conversion efficiency of Nanogroup SA from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Nanogroup SA.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 zł15.93 Million
≈ $4.38 Million
zł-5.72 Million
≈ $-1.57 Million
-0.359x +61.11%
2023-12-31 zł5.16 Million
≈ $1.42 Million
zł-4.76 Million
≈ $-1.31 Million
-0.923x -94.91%
2022-12-31 zł7.78 Million
≈ $2.14 Million
zł-3.68 Million
≈ $-1.01 Million
-0.473x -23.81%
2021-12-31 zł8.37 Million
≈ $2.30 Million
zł-3.20 Million
≈ $-880.44K
-0.382x -432.65%
2020-12-31 zł18.77 Million
≈ $5.16 Million
zł-1.35 Million
≈ $-370.81K
-0.072x +39.41%
2019-12-31 zł13.31 Million
≈ $3.66 Million
zł-1.58 Million
≈ $-434.00K
-0.118x +47.04%
2018-12-31 zł15.52 Million
≈ $4.27 Million
zł-3.47 Million
≈ $-955.84K
-0.224x -22.01%
2017-12-31 zł14.17 Million
≈ $3.90 Million
zł-2.60 Million
≈ $-714.92K
-0.183x -202.75%
2016-12-31 zł12.75 Million
≈ $3.51 Million
zł-772.07K
≈ $-212.49K
-0.061x -153.46%
2015-12-31 zł5.28 Million
≈ $1.45 Million
zł-126.11K
≈ $-34.71K
-0.024x --

About Nanogroup SA

WAR:NNG Poland Biotechnology
Market Cap
$20.32 Million
zł73.82 Million PLN
Market Cap Rank
#25076 Global
#254 in Poland
Share Price
zł2.30
Change (1 day)
+0.44%
52-Week Range
zł2.29 - zł3.12
All Time High
zł13.00
About

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.